New Enterprise Associates 16, L.P.
Insider CIK 1694560 · MRKR 10% owner · GNCA 10% owner · RGLS 10% owner · TRVI 10% owner · MTCR 10% owner · NEUE Director, 10% owner · AKUS 10% owner · MIRM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 372,255 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 372,255 | — | $0 | 372,255 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 788,259 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 787,979 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 372,255 | $0.01 | $3.7K | 1,160,234 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 551 | $6.75 | $3.7K | 1,159,683 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 1,159,683 | — | $0 | 0 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2024-12-23 | 2024-12-23 | 554,250 | $3.20 | $1.77M | 1,625,678 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 2,000,000 | — | $0 | 2,186,243 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 4,294,207 | — | $0 | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 2,631,578 | $1.90 | $5.00M | 10,421,428 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 170,932 | $0.91 | $155.5K | 2,563,257 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 288,768 | $1.00 | $288.8K | 2,734,189 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-10 | 2021-12-27 | 37,570 | $1.32 | $49.6K | 3,022,957 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 1,851,852 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 1,851,852 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 7,789,850 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 258,707 | $6.22 | $1.61M | 258,707 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 5,239,254 | $0.13 | $681.1K | 5,239,254 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2020-12-04 | 2020-12-07 | 4,398,602 | $0.62 | $2.73M | 6,451,056 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 2,291,297 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 769,230 | $13.00 | $10.00M | 3,060,527 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 1,958,333 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 513,758 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 2,505,996 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 588,235 | $17.00 | $10.00M | 4,294,207 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 3,705,972 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise deriv | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 5,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2020-04-03 | 2020-04-13 | 564 | $2.66 | $1.5K | 5,937,998 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 900,900 | $6.66 | $6.00M | 900,900 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 9,009,000 | $0.13 | $1.17M | 9,009,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 29,889,945 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 3,736,243 | — | $0 | 3,736,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 450,000 | $15.00 | $6.75M | 4,186,243 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 17,099,315 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 1,938,562 | — | $0 | 1,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,000,000 | $10.00 | $10.00M | 2,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,500,000 | $10.00 | $15.00M | 4,438,562 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 256,700 | $10.80 | $2.77M | 256,700 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 3,703,704 | $0.13 | $481.5K | 3,703,704 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2019-05-07 | 2019-05-09 | 1,136,704 | $1.08 | $1.23M | 2,052,454 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |